PATENT CLAIM ANALYSIS

Application Number: 16230512
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "191100"]

Abstract:
The present invention provides polypeptides useful as antigens expressed at the pre-erythrocytic stage of the malaria parasite. The antigens can be utilized to induce an immune response and sterile protection against malaria in a mammal by administering the antigens in vaccine formulations or expressing the antigens in DNA or other recombinant protein expression systems delivered as a vaccine formulation.

Claim (Index 30):
The method of  claim 14 , wherein the composition is formulated as an ampule, a pre-filled syringe, a small volume infusion container, or in multi-dose containers with an added preservative.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 98.0
- Lexical Diversity: 1.32609
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15431609', '14219390', '12928044', '11143986', '11975396']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8259471171436316
- 35 USC 102 Novelty (BERT): 0.627415417737594
- Combined Prediction Score: 0.8060939472030277
- Mean Citation Score: 510.18833400000005
- Max Citation Score: 789.22186
- Similarity Product: 513.8686877388237

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test